Jean Blier

Learn More
T he rapid and robust antidepressant effect of the intravenous infusion of a subanesthetic dose of ketamine in 2000 has triggered research endeavors in this novel mechanism of action (1-5). Its drug abuse potential and early reports of neuro-nal toxicity in rats are likely contributing to slowing the clinical progress (6). Ketamine is a dissociative(More)
  • 1